China Universal Asset Management Co., Ltd. Biocryst Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 43,920 shares of BCRX stock, worth $411,091. This represents 0.03% of its overall portfolio holdings.
Number of Shares
43,920
Previous 39,791
10.38%
Holding current value
$411,091
Previous $302,000
9.27%
% of portfolio
0.03%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$205 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$187 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$111 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$85 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$76.2 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.74B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...